US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 8.600
  • -0.230-2.60%
Close Nov 29 13:00 ET
  • 8.600
  • 0.0000.00%
Post 13:02 ET
182.27MMarket Cap-1569P/E (TTM)

Enanta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enanta Pharmaceuticals Q4 2024 Earnings Date

Currency：USDNov 25, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
17.83M
14.61M
-3.22M
Miss Est.
-5.83%
-22.84%
-18.07%
EPS
-1.07
-1.36
-0.29
Miss Est.
+19.33%
-2.26%
-26.77%
Analyst Rating
Buy

Nov 30, 2024

Enanta Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 16.133M--
--2025/Q1-- / 18.499M--
Nov 25, 20242024/Q414.607M / 17.828M--
Aug 5, 20242024/Q317.971M / 17.156M--
May 6, 20242024/Q217.054M / 16.207M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 16.133M--
--2025/Q1-- / 18.499M--
Nov 25, 20242024/Q414.607M / 17.828M--
Aug 5, 20242024/Q317.971M / 17.156M--
May 6, 20242024/Q217.054M / 16.207M--

Unlock Free Earnings Estimates

Enanta Pharmaceuticals Earnings Reports

  • Enanta Pharmaceuticals | 10-K: FY2024 Annual Report

    Nov 27 08:38 ET

  • Enanta Pharmaceuticals | 8-K: Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024

    Nov 25 16:09 ET

  • Enanta Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Aug 7 16:02 ET

  • Enanta Pharmaceuticals | 8-K: Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter

    Aug 5 16:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      50.00%

    • Hold

      33.33%

    • Sell

      16.67%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data